Professional Summary
Professional Overview
Anthony Magliocco is an accomplished healthcare executive and academic leader with extensive expertise in pathology, diagnostics, and oncology research. As the President and CEO of Protean Biodiagnostics Inc., he leverages his deep scientific and operational acumen to drive innovation in the field of biomedical diagnostics. Additionally, he serves as a Professor of Pathology at the University of Central Florida, where he shares his industry insights and technical knowledge with the next generation of healthcare professionals.
Experience Summary
Current Role
As the President and CEO of Protean Biodiagnostics Inc. since 2017, Anthony Magliocco leads the strategic direction and day-to-day operations of the company. Under his leadership, Protean Biodiagnostics has developed several groundbreaking diagnostic platforms that have improved patient outcomes in oncology. Magliocco's extensive experience in pathology and laboratory management has been instrumental in positioning Protean as a leading innovator in the field of biomedical diagnostics.
In his concurrent role as a Professor of Pathology at the University of Central Florida, Magliocco shares his expertise in pathology, oncology, and diagnostic technologies with students and researchers. His teaching and mentorship have been instrumental in nurturing the next generation of healthcare leaders.
Career Progression
Prior to his current roles, Magliocco held several senior-level positions at Moffitt Cancer Center, where he served as the Chair of Anatomical Pathology, Executive Director of Esoteric Laboratory Services, and Scientific Director. In these roles, he spearheaded the development of advanced diagnostic tools and collaborative research initiatives that have had a significant impact on cancer care.
Earlier in his career, Magliocco served as the Director of Pathology at the Tom Baker Cancer Centre in Canada and a Post-Doctoral Fellow in Molecular Surgical Pathology at the Fox Chase Cancer Center in the United States.
Academic Background
Magliocco holds a Doctor of Medicine (M.D.) degree and has completed extensive post-graduate training in pathology and oncology research. His academic and research achievements have been recognized through his appointment as the Chair of the Pathology Committee at the Radiation Therapy Oncology Group (RTOG).
Areas of Expertise
- Pathology and diagnostic test development
- Oncology research and clinical care
- Esoteric laboratory services and operations
- Academic leadership and teaching
- Translational research and innovative diagnostics
Professional Impact
Throughout his career, Magliocco has made significant contributions to the field of healthcare and diagnostics. His work has led to the development of several novel diagnostic platforms that have improved patient outcomes in oncology. Additionally, his leadership in academic and research settings has been instrumental in advancing the field of pathology and oncology.
Conclusion
With his extensive experience, proven track record of innovation, and deep industry expertise, Anthony Magliocco is a respected leader in the healthcare and diagnostics sectors. In his current roles as President and CEO of Protean Biodiagnostics and Professor of Pathology at the University of Central Florida, he continues to drive advancements in the field of biomedical diagnostics and shape the next generation of healthcare professionals.
